Christopher L. Bowlus - Publications

University of California, Davis, Davis, CA 
Immunology, Molecular Biology

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Song J, Li Y, Bowlus CL, Yang G, Leung PSC, Gershwin ME. Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review. Clinical Reviews in Allergy & Immunology. PMID 31463807 DOI: 10.1007/s12016-019-08764-7  0.4
2019 Bowlus CL, Yang GX, Liu CH, Johnson CR, Dhaliwal SS, Frank D, Levy C, Peters MG, Vierling JM, Gershwin ME. Therapeutic trials of biologics in primary biliary cholangitis: An open label study of abatacept and review of the literature. Journal of Autoimmunity. PMID 31027870 DOI: 10.1016/j.jaut.2019.04.005  0.4
2018 Floreani A, Restrepo-Jiménez P, Secchi MF, De Martin S, Leung PSC, Krawitt E, Bowlus CL, Gershwin ME, Anaya JM. Etiopathogenesis of autoimmune hepatitis. Journal of Autoimmunity. PMID 30385083 DOI: 10.1016/j.jaut.2018.10.020  0.4
2017 Yao M, Wang L, Leung PSC, Li Y, Liu S, Wang L, Guo X, Zhou G, Yan Y, Guan G, Chen X, Bowlus CL, Liu T, Jia J, Gershwin ME, et al. The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review. Clinical Reviews in Allergy & Immunology. PMID 29256057 DOI: 10.1007/s12016-017-8655-y  0.4
2017 Bowlus CL, Olson KA, Gershwin ME. Evaluation of indeterminate biliary strictures. Nature Reviews. Gastroenterology & Hepatology. PMID 29094722 DOI: 10.1038/nrgastro.2017.154  0.4
2017 Tanaka T, Zhang W, Sun Y, Shuai Z, Chida A, Kenny TP, Yang GX, Sanz I, Ansai A, Bowlus CL, Ippolito GC, Coppel RL, Okazaki K, He XS, Leung PSC, et al. Autoreactive Monoclonal Antibodies from Patients with Primary Biliary Cholangitis Recognize Environmental Xenobiotics. Hepatology (Baltimore, Md.). PMID 28470667 DOI: 10.1002/hep.29245  0.4
2016 Wang Z, Sheng L, Yang Y, Yang F, Xiao X, Hua J, Guo C, Wei Y, Tang R, Miao Q, Zhang J, Li Y, Fang J, Qiu D, Krawitt EL, ... Bowlus CL, et al. The Management of Autoimmune Hepatitis Patients with Decompensated Cirrhosis: Real-World Experience and a Comprehensive Review. Clinical Reviews in Allergy & Immunology. PMID 27515672 DOI: 10.1007/s12016-016-8583-2  0.4
2016 Sun Y, Zhang W, Evans JF, Floreani A, Zou Z, Nishio Y, Qi R, Leung PS, Bowlus CL, Gershwin ME. Autotaxin, Pruritus and Primary Biliary Cholangitis (PBC). Autoimmunity Reviews. PMID 27019050 DOI: 10.1016/j.autrev.2016.03.019  0.4
2015 Floreani A, Sun Y, Zou ZS, Li B, Cazzagon N, Bowlus CL, Gershwin ME. Proposed therapies in primary biliary cholangitis. Expert Review of Gastroenterology & Hepatology. PMID 26577047 DOI: 10.1586/17474124.2016.1121810  0.4
2015 Bowlus CL, Olson KA, Gershwin ME. Evaluation of indeterminate biliary strictures. Nature Reviews. Gastroenterology & Hepatology. PMID 26526122 DOI: 10.1038/nrgastro.2015.182  0.4
2015 Tomiyama T, Yang GX, Zhao M, Zhang W, Tanaka H, Wang J, Leung PS, Okazaki K, He XS, Lu Q, Coppel RL, Bowlus CL, Gershwin ME. The modulation of co-stimulatory molecules by circulating exosomes in primary biliary cirrhosis. Cellular & Molecular Immunology. PMID 26388238 DOI: 10.1038/cmi.2015.86  0.4
2015 Rong G, Wang H, Bowlus CL, Wang C, Lu Y, Zeng Z, Qu J, Lou M, Chen Y, An L, Yang Y, Gershwin ME. Incidence and risk factors for hepatocellular carcinoma in primary biliary cirrhosis. Clinical Reviews in Allergy & Immunology. 48: 132-41. PMID 25762349 DOI: 10.1007/s12016-015-8483-x  0.4
2015 Mousa HS, Lleo A, Invernizzi P, Bowlus CL, Gershwin ME. Advances in pharmacotherapy for primary biliary cirrhosis. Expert Opinion On Pharmacotherapy. 16: 633-43. PMID 25543678 DOI: 10.1517/14656566.2015.998650  0.4
2015 Floreani A, Franceschet I, Perini L, Cazzagon N, Gershwin ME, Bowlus CL. New therapies for primary biliary cirrhosis. Clinical Reviews in Allergy & Immunology. 48: 263-72. PMID 25331740 DOI: 10.1007/s12016-014-8456-5  0.4
2015 Norman GL, Yang CY, Ostendorff HP, Shums Z, Lim MJ, Wang J, Awad A, Hirschfield GM, Milkiewicz P, Bloch DB, Rothschild KJ, Bowlus CL, Adamopoulos IE, Leung PS, Janssen HJ, et al. Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis. Liver International : Official Journal of the International Association For the Study of the Liver. 35: 642-51. PMID 25243383 DOI: 10.1111/liv.12690  0.4
2014 Zhang J, Zhang W, Leung PS, Bowlus CL, Dhaliwal S, Coppel RL, Ansari AA, Yang GX, Wang J, Kenny TP, He XS, Mackay IR, Gershwin ME. Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosis. Hepatology (Baltimore, Md.). 60: 1708-16. PMID 25043065 DOI: 10.1002/hep.27313  0.4
2014 Bowlus CL, Gershwin ME. The diagnosis of primary biliary cirrhosis. Autoimmunity Reviews. 13: 441-4. PMID 24424173 DOI: 10.1016/j.autrev.2014.01.041  0.4
2014 Yang CY, Ma X, Tsuneyama K, Huang S, Takahashi T, Chalasani NP, Bowlus CL, Yang GX, Leung PS, Ansari AA, Wu L, Coppel RL, Gershwin ME. IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy. Hepatology (Baltimore, Md.). 59: 1944-53. PMID 24375552 DOI: 10.1002/hep.26979  0.4
2012 Tanaka H, Leung PS, Kenny TP, Gershwin ME, Bowlus CL. Immunological orchestration of liver fibrosis. Clinical Reviews in Allergy & Immunology. 43: 220-9. PMID 22695942 DOI: 10.1007/s12016-012-8323-1  0.4
2012 Kawata K, Kobayashi Y, Gershwin ME, Bowlus CL. The immunophysiology and apoptosis of biliary epithelial cells: primary biliary cirrhosis and primary sclerosing cholangitis. Clinical Reviews in Allergy & Immunology. 43: 230-41. PMID 22689287 DOI: 10.1007/s12016-012-8324-0  0.4
2012 Tsuda M, Moritoki Y, Lian ZX, Zhang W, Yoshida K, Wakabayashi K, Yang GX, Nakatani T, Vierling J, Lindor K, Gershwin ME, Bowlus CL. Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid. Hepatology (Baltimore, Md.). 55: 512-21. PMID 22006563 DOI: 10.1002/hep.24748  0.4
2011 Tsuda M, Ambrosini YM, Zhang W, Yang GX, Ando Y, Rong G, Tsuneyama K, Sumida K, Shimoda S, Bowlus CL, Leung PS, He XS, Coppel RL, Ansari AA, Lian ZX, et al. Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosis. Hepatology (Baltimore, Md.). 54: 1293-302. PMID 21735469 DOI: 10.1002/hep.24526  0.4
2011 Zhang W, Ono Y, Miyamura Y, Bowlus CL, Gershwin ME, Maverakis E. T cell clonal expansions detected in patients with primary biliary cirrhosis express CX3CR1. Journal of Autoimmunity. 37: 71-8. PMID 21636249 DOI: 10.1016/j.jaut.2011.05.009  0.4
2011 Selmi C, Bowlus CL, Gershwin ME, Coppel RL. Primary biliary cirrhosis. Lancet (London, England). 377: 1600-9. PMID 21529926 DOI: 10.1016/S0140-6736(10)61965-4  0.4
2011 Rong G, Zhong R, Lleo A, Leung PS, Bowlus CL, Yang GX, Yang CY, Coppel RL, Ansari AA, Cuebas DA, Worman HJ, Invernizzi P, Gores GJ, Norman G, He XS, et al. Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis. Hepatology (Baltimore, Md.). 54: 196-203. PMID 21488079 DOI: 10.1002/hep.24355  0.4
2010 Lleo A, Bowlus CL, Yang GX, Invernizzi P, Podda M, Van de Water J, Ansari AA, Coppel RL, Worman HJ, Gores GJ, Gershwin ME. Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology (Baltimore, Md.). 52: 987-98. PMID 20568301 DOI: 10.1002/hep.23783  0.4
2008 Selmi C, Zuin M, Bowlus CL, Gershwin ME. Anti-mitochondrial antibody-negative primary biliary cirrhosis. Clinics in Liver Disease. 12: 173-85, ix. PMID 18242503 DOI: 10.1016/j.cld.2007.11.008  0.4
2007 Selmi C, Bowlus CL, Keen CL, Gershwin ME. Non-alcoholic fatty liver disease: the new epidemic and the need for novel nutritional approaches. Journal of Medicinal Food. 10: 563-5. PMID 18158823 DOI: 10.1089/jmf.2007.620  0.4
2007 Selmi C, Gershwin ME, Lindor KD, Worman HJ, Gold EB, Watnik M, Utts J, Invernizzi P, Kaplan MM, Vierling JM, Bowlus CL, Silveira MG, Bossi I. Quality of life and everyday activities in patients with primary biliary cirrhosis. Hepatology (Baltimore, Md.). 46: 1836-43. PMID 18027862 DOI: 10.1002/hep.21953  0.4
2006 Aoki CA, Dawson K, Kenny TP, Gershwin ME, Bowlus CL. Gene expression by PBMC in primary sclerosing cholangitis: evidence for dysregulation of immune mediated genes. Clinical & Developmental Immunology. 13: 265-71. PMID 17162367 DOI: 10.1080/17402520600800085  0.4
2006 Lan RY, Cheng C, Lian ZX, Tsuneyama K, Yang GX, Moritoki Y, Chuang YH, Nakamura T, Saito S, Shimoda S, Tanaka A, Bowlus CL, Takano Y, Ansari AA, Coppel RL, et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology (Baltimore, Md.). 43: 729-37. PMID 16557534 DOI: 10.1002/hep.21123  0.4
2006 Ichiki Y, Bowlus CL, Shimoda S, Ishibashi H, Vierling JM, Gershwin ME. T cell immunity and graft-versus-host disease (GVHD). Autoimmunity Reviews. 5: 1-9. PMID 16338205 DOI: 10.1016/j.autrev.2005.02.006  0.4
2005 Aoki CA, Borchers AT, Li M, Flavell RA, Bowlus CL, Ansari AA, Gershwin ME. Transforming growth factor beta (TGF-beta) and autoimmunity. Autoimmunity Reviews. 4: 450-9. PMID 16137611 DOI: 10.1016/j.autrev.2005.03.006  0.4
2005 Ichiki Y, Aoki CA, Bowlus CL, Shimoda S, Ishibashi H, Gershwin ME. T cell immunity in autoimmune hepatitis. Autoimmunity Reviews. 4: 315-21. PMID 15990080 DOI: 10.1016/j.autrev.2005.01.005  0.4
2005 Aoki CA, Bowlus CL, Gershwin ME. The immunobiology of primary sclerosing cholangitis. Autoimmunity Reviews. 4: 137-43. PMID 15823499 DOI: 10.1016/j.autrev.2004.09.003  0.4
2005 Cheunsuk S, Lian ZX, Yang GX, Gershwin ME, Gruen JR, Bowlus CL. Prss16 is not required for T-cell development. Molecular and Cellular Biology. 25: 789-96. PMID 15632078 DOI: 10.1128/MCB.25.2.789-796.2005  0.4
2003 Wu CT, Eiserich JP, Ansari AA, Coppel RL, Balasubramanian S, Bowlus CL, Gershwin ME, Van De Water J. Myeloperoxidase-positive inflammatory cells participate in bile duct damage in primary biliary cirrhosis through nitric oxide-mediated reactions. Hepatology (Baltimore, Md.). 38: 1018-25. PMID 14512889 DOI: 10.1053/jhep.2003.50407  0.4
2002 Cheunsuk S, Hsu T, Gershwin ME, Bowlus CL. Analysis of the IDDM candidate gene Prss16 in NOD and NON mice. Developmental Immunology. 9: 183-6. PMID 15144014  0.4
2002 Cheunsuk S, Sparks R, Noveroske JK, Hsu T, Justice MJ, Gershwin ME, Gruen JR, Bowlus CL. Expression, genomic structure and mapping of the thymus specific protease prss16: a candidate gene for insulin dependent diabetes mellitus susceptibility. Journal of Autoimmunity. 18: 311-6. PMID 12144812  0.4
Show low-probability matches.